CZEN-002 is a synthetic small molecule belonging to the kinase inhibitor class, specifically designed to target the c-Met receptor tyrosine kinase involved in cellular proliferation and migration. This… Read more
CZEN-002 is a synthetic small molecule belonging to the kinase inhibitor class, specifically designed to target the c-Met receptor tyrosine kinase involved in cellular proliferation and migration. This compound is primarily investigated for its therapeutic potential in the treatment of solid tumors driven by overactive c-Met signaling pathways. Analytical laboratories require high-quality reference standards for CZEN-002, including related impurities, metabolic degradation products, and stable isotope-labelled standards, to support rigorous pharmaceutical research. These materials are essential for developing and validating accurate analytical methods, such as liquid chromatography-mass spectrometry (LC-MS) and high-resolution mass spectrometry. By utilizing these precise reference materials, researchers can perform effective impurity profiling, accurately quantify metabolite concentrations, and maintain strict quality control protocols throughout the drug development lifecycle, ensuring the reliability and safety of their analytical results.